TotalMarketCap

Maxcyte

MXCTNasdaq United StatesHealth CareBiotechnology: Commercial Physical & Biological Resarch

Market cap

$135.200 M

$1.31 -5.75%

Close of 6 Nov 2026

As of 6 Nov 2026, Maxcyte (MXCT) has a market capitalization of $135.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$33.0M

#2838 by revenue

Earnings

-$44.6M

Loss-making

Shares outstanding

103,206,206

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →
  1. #7OmniAbOABI$706.7M
  2. #8Nrc HealthNRC$538.5M
  3. #9MaxcyteMXCT$135.2M
  4. #10OneMedNetONMD$25.4M
  5. #11bioAffinity TechnologiesBIAF$4.91M

What if Maxcyte were worth as much as…

Open the what-if tool →

Gold $28.2T

$273,596.67

Per share 208,852× higher

Bitcoin $1.53T

$14,803.84

Per share 11,301× higher

Apple $5.02T

$48,599.62

Per share 37,099× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Maxcyte are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.